These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 19524925

  • 1. Prothrombin and risk of venous thromboembolism, ischemic heart disease and ischemic cerebrovascular disease in the general population.
    Weischer M, Juul K, Zacho J, Jensen GB, Steffensen R, Schroeder TV, Tybjaerg-Hansen A, Nordestgaard BG.
    Atherosclerosis; 2010 Feb; 208(2):480-3. PubMed ID: 19524925
    [Abstract] [Full Text] [Related]

  • 2. Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism.
    Emmerich J, Rosendaal FR, Cattaneo M, Margaglione M, De Stefano V, Cumming T, Arruda V, Hillarp A, Reny JL.
    Thromb Haemost; 2001 Sep; 86(3):809-16. PubMed ID: 11583312
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Risk of recurrent venous thrombosis in homozygous carriers and double heterozygous carriers of factor V Leiden and prothrombin G20210A.
    Lijfering WM, Middeldorp S, Veeger NJ, Hamulyák K, Prins MH, Büller HR, van der Meer J.
    Circulation; 2010 Apr 20; 121(15):1706-12. PubMed ID: 20368522
    [Abstract] [Full Text] [Related]

  • 6. Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives.
    Aznar J, Vayá A, Estellés A, Mira Y, Seguí R, Villa P, Ferrando F, Falcó C, Corella D, España F.
    Haematologica; 2000 Dec 20; 85(12):1271-6. PubMed ID: 11114134
    [Abstract] [Full Text] [Related]

  • 7. Heterozygosity for R1141X in ABCC6 and risk of ischemic vascular disease.
    Hornstrup LS, Tybjærg-Hansen A, Haase CL, Nordestgaard BG, Sillesen H, Grande P, Frikke-Schmidt R.
    Circ Cardiovasc Genet; 2011 Oct 20; 4(5):534-41. PubMed ID: 21831958
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The thrombophilic pattern of different clinical manifestations of venous thromboembolism: a survey of 443 cases of venous thromboembolism.
    Grifoni E, Marcucci R, Ciuti G, Cenci C, Poli D, Mannini L, Liotta AA, Miniati M, Abbate R, Prisco D.
    Semin Thromb Hemost; 2012 Mar 20; 38(2):230-4. PubMed ID: 22422337
    [Abstract] [Full Text] [Related]

  • 11. The VITA project: prothrombin G20210A mutation and venous thromboembolism in the general population.
    Tosetto A, Missiaglia E, Frezzato M, Rodeghiero F.
    Thromb Haemost; 1999 Nov 20; 82(5):1395-8. PubMed ID: 10595625
    [Abstract] [Full Text] [Related]

  • 12. Genetically reduced antioxidative protection and increased ischemic heart disease risk: The Copenhagen City Heart Study.
    Juul K, Tybjaerg-Hansen A, Marklund S, Heegaard NH, Steffensen R, Sillesen H, Jensen G, Nordestgaard BG.
    Circulation; 2004 Jan 06; 109(1):59-65. PubMed ID: 14662715
    [Abstract] [Full Text] [Related]

  • 13. Predictive value of factor V Leiden and prothrombin G20210A in adults with venous thromboembolism and in family members of those with a mutation: a systematic review.
    Segal JB, Brotman DJ, Necochea AJ, Emadi A, Samal L, Wilson LM, Crim MT, Bass EB.
    JAMA; 2009 Jun 17; 301(23):2472-85. PubMed ID: 19531787
    [Abstract] [Full Text] [Related]

  • 14. Zinc Finger Protein 202: a new candidate gene for ischemic heart disease: The Copenhagen City Heart Study.
    Stene MC, Frikke-Schmidt R, Nordestgaard BG, Steffensen R, Schnohr P, Tybjaerg-Hansen A.
    Atherosclerosis; 2006 Sep 17; 188(1):43-50. PubMed ID: 16289551
    [Abstract] [Full Text] [Related]

  • 15. Lower contribution of factor V Leiden or G202104 mutations to ischemic stroke in patients with clinical risk factors: pair-matched case-control study.
    Eterović D, Titlić M, Culić V, Zadro R, Primorac D.
    Clin Appl Thromb Hemost; 2007 Apr 17; 13(2):188-93. PubMed ID: 17456629
    [Abstract] [Full Text] [Related]

  • 16. Prevalence of factor V Leiden and prothrombin G20210A mutations in unselected patients with venous thromboembolism.
    de Moerloose P, Reber G, Perrier A, Perneger T, Bounameaux H.
    Br J Haematol; 2000 Jul 17; 110(1):125-9. PubMed ID: 10930988
    [Abstract] [Full Text] [Related]

  • 17. Observationally and Genetically High YKL-40 and Risk of Venous Thromboembolism in the General Population: Cohort and Mendelian Randomization Studies.
    Kjaergaard AD, Johansen JS, Bojesen SE, Nordestgaard BG.
    Arterioscler Thromb Vasc Biol; 2016 May 17; 36(5):1030-6. PubMed ID: 26988593
    [Abstract] [Full Text] [Related]

  • 18. Factor V Leiden (G1691A) and prothrombin gene G20210A mutations as potential risk factors for venous thromboembolism after total hip or total knee replacement surgery.
    Wåhlander K, Larson G, Lindahl TL, Andersson C, Frison L, Gustafsson D, Bylock A, Eriksson BI.
    Thromb Haemost; 2002 Apr 17; 87(4):580-5. PubMed ID: 12008938
    [Abstract] [Full Text] [Related]

  • 19. The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation.
    De Stefano V, Martinelli I, Mannucci PM, Paciaroni K, Chiusolo P, Casorelli I, Rossi E, Leone G.
    N Engl J Med; 1999 Sep 09; 341(11):801-6. PubMed ID: 10477778
    [Abstract] [Full Text] [Related]

  • 20. Are patients with thrombophilia and previous venous thromboembolism at higher risk to arterial thrombosis?
    Linnemann B, Schindewolf M, Zgouras D, Erbe M, Jarosch-Preusche M, Lindhoff-Last E.
    Thromb Res; 2008 Sep 09; 121(6):743-50. PubMed ID: 17804043
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.